慢性肢体威胁性缺血与糖尿病足溃疡管理延迟的系统综述
OBJECTIVE: Patients presenting with chronic limb-threatening ischemia and diabetic foot ulceration (DFU) are at high risk of major lower limb amputation. Long-standing concern exists regarding late presentation and delayed management contributing to increased amputation rates.…
要点
- 慢性肢体威胁性缺血和糖尿病足溃疡的管理路径各环节均存在延迟。
- 症状出现至专科评估中位时间15-126天,评估至治疗中位时间1-91天。
- 延迟原因涉及患者就医行为、医疗评估准确性和转诊治疗障碍。
核心结论
- 管理路径各环节存在时间延迟,部分延迟时间相当长。
- 延迟原因复杂,反映患者就医行为差、医疗评估不准确及转诊治疗障碍。
- 需要制定标准化转诊和治疗时间限制、探索漏诊机会及研究提供专科护理的新策略。
研究设计与样本
- 纳入调查或报告高收入国家(人均年GDP>15000美元)时间延迟的识别、原因和结局的英文定性和定量文章。
- 共筛选4780篇文章,最终纳入32篇,涉及71,310例患者和1388名医护人员。
- 研究方案在国际前瞻性系统综述注册平台注册。
主要发现
- 仅12篇文章被认为高质量,异质性显著。
- 仅4篇文章定义了延迟,但研究间不一致。
- 症状出现至专科医疗评估的中位时间范围为15至126天,评估至治疗的中位时间范围为1至91天。
- 20篇文章报告延迟结局,包括大截肢率、溃疡愈合和全因死亡率,结果异质但提示延迟与不良结局相关。
临床怎么用
- 临床应关注慢性肢体威胁性缺血和糖尿病足溃疡管理路径中的时间延迟。
- 需标准化转诊和治疗时间限制以减少延迟。
- 应探索漏诊机会并研究提供专科护理的新策略。
局限性
- 研究间异质性显著。
- 仅12篇文章被认为高质量。
- 仅4篇文章定义了延迟且不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients presenting with chronic limb-threatening ischemia and diabetic foot ulceration (DFU) are at high risk of major lower limb amputation. Long-standing concern exists regarding late presentation and delayed management contributing to increased amputation rates. Despite multiple guidelines existing on the management of both conditions, there is currently no accepted time frame in which to enact specialist care and treatment. This systematic review aimed to investigate potential time delays in the identification, referral, and management of both chronic limb-threatening ischemia and DFU. METHODS: A systematic review conforming to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement standards was performed searching MEDLINE, Embase, The Cochrane Library, and Cumulative Index to Nursing and Allied Health Literature from inception to November 14, 2018. All English-language qualitative and quantitative articles investigating or reporting the identification, causes, and outcomes of time delays within "high-income" countries (annual gross domestic product per person >$15,000) were included. Data were extracted independently by the investigators. Given the clinical crossover, both conditions were investigated together. A study protocol was designed and registered at the International Prospective Register of Systematic Reviews. RESULTS: A total of 4780 articles were screened, of which 32 articles, involving 71,310 patients and 1388 health care professionals, were included. Twenty-three articles focused predominantly on DFU. Considerable heterogeneity was noted, and only 12 articles were deemed of high quality. Only four articles defined a delay, but this was not consistent between studies. Median times from symptom onset to specialist health care assessment ranged from 15 to 126 days, with subsequent median times from assessment to treatment ranging from 1 to 91 days. A number of patient and health care factors were consistently reported as potentially causative, including poor symptom recognition by the patient, inaccurate health care assessment, and difficulties in accessing specialist services. Twenty articles reported outcomes of delays, namely, rates of major amputation, ulcer healing, and all-cause mortality. Although results were heterogeneous, they allude to delays being associated with detrimental outcomes for patients. CONCLUSIONS: Time delays exist in all aspects of the management pathway, which are in some cases considerable in length. The causes of these are complex but reflect poor patient health-seeking behaviors, inaccurate health care assessment, and barriers to referral and treatment within the care pathway. The adoption of standardized limits for referral and treatment times, exploration of missed opportunities for diagnosis, and investigation of novel strategies for providing specialist care are required to help reduce delays.
引用
- Nickinson ATO, Bridgwood B, Houghton JSM, et al. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration. J Vasc Surg. 2019. PMID: 31676182. doi:10.1016/j.jvs.2019.08.229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。